Cargando…
Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide
Background: Narcotic agents are frequently administered to manage increased intestinal motility in patients with short bowel syndrome, but long-term use is associated with gastrointestinal (GI) complaints. This analysis evaluated the incidence of narcotic use and abdominal adverse events among patie...
Autores principales: | Fujioka, Ken, Jeejeebhoy, Khursheed, Pape, Ulrich-Frank, Li, Benjamin, Youssef, Nader N., Schneider, Stéphane M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703028/ https://www.ncbi.nlm.nih.gov/pubmed/27507402 http://dx.doi.org/10.1177/0148607116663481 |
Ejemplares similares
-
Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome
por: Schwartz, Lauren K, et al.
Publicado: (2016) -
Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome
por: Iyer, Kishore R., et al.
Publicado: (2016) -
Teduglutide for short bowel syndrome
Publicado: (2020) -
Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials
por: Pape, Ulrich-Frank, et al.
Publicado: (2020) -
Predictive Potential of Biomarkers of Intestinal Barrier Function for Therapeutic Management with Teduglutide in Patients with Short Bowel Syndrome
por: Büttner, Janine, et al.
Publicado: (2023)